MilatF, RamchandSK, HerathM, et al.Primary hyperparathyroidism in adults—(part I) assessment and medical management: Position statement of the Endocrine Society of Australia, the Australian & New Zealand Endocrine Surgeons, and the Australian & New Zealand Bone and Mineral Society. Clin Endocrinol (Oxf)2024;100(1)3-18; doi: 10.1111/cen.14659.
2.
WilhelmSM, WangTS, RuanDT, et al.The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg2016;151(10):959-968; doi: 10.1001/jamasurg.2016.2310.
3.
BilezikianJP, KhanAA, SilverbergSJ, et al.Evaluation and management of primary hyperparathyroidism: Summary statement and guidelines from the fifth international workshop. J Bone Miner Res2022;37(11):2293-2314; doi: 10.1002/jbmr.4677.
4.
PasiekaJL, ParsonsLL, DemeureMJ, et al.Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism. World J Surg2002;26(8):942-949; doi: 10.1007/s00268-002-6623-y.
5.
MorrisGS, GrubbsEG, HearonCM, et al.Parathyroidectomy improves functional capacity in “asymptomatic” older patients with primary hyperparathyroidism: A randomized control trial. Ann Surg2010;251(5):832-837; doi: 10.1097/SLA.0b013e3181d76bb3.
6.
Björnsdotter-ÖbergS, KomanA, SkorpilM, et al.Parathyroidectomy restores muscle strength and transcriptome in individuals with primary hyperparathyroidism. J Clin Endocrinol Metab2026;111(2):366-374; doi: 10.1210/clinem/dgaf418.
7.
PillonNJ, GabrielBM, DolletL, et al.Transcriptomic profiling of skeletal muscle adaptations to exercise and inactivity. Nat Commun.2020;11(1):470; doi: 10.1038/s41467-019-13869-w.
8.
AmbroginiE, CetaniF, CianferottiL, et al.Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: A prospective, randomized clinical trial. J Clin Endocrinol Metab2007;92(8):3114-3121; doi: 10.1210/jc.2007-0219.
9.
SheldonDG, LeeFT, NeilNJ, RyanJA. Surgical treatment of hyperparathyroidism improves health-related quality of life. Arch Surg2002;137(9):1022-1028; doi: 10.1001/archsurg.137.9.1022.
10.
SongZ, BalachandraS, WuC, et al.Risk of neuropsychiatric disorders in primary hyperparathyroidism: Parathyroidectomy versus nonoperative management. World J Surg2025;49(1):106-114; doi: 10.1002/wjs.12285.
11.
MillerJA, GundaraJ, HarperS, et al.Primary hyperparathyroidism in adults—(Part II) surgical management and postoperative follow-up: Position statement of the Endocrine Society of Australia, The Australian & New Zealand Endocrine Surgeons, and the Australian & New Zealand Bone and Mineral Society. Clin Endocrinol (Oxf)2024;101(5):516-530; doi: 10.1111/cen.14650.
12.
AsbanA, DombrowskyA, MallickR, et al.Failure to diagnose and treat hyperparathyroidism among patients with hypercalcemia: Opportunities for intervention at the patient and physician level to increase surgical referral. Oncologist2019;24(9):e828-e834; doi: 10.1634/theoncologist.2018-0424.
13.
WuC, GillisA, SidaniM, et al.Thresholds for surgical referral in primary hyperparathyroidism: A conjoint analysis. Am J Surg2023;226(5):640-645; doi: 10.1016/j.amjsurg.2023.07.010.
